Clinical Trial Update: Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer

View source ↗

Summary

This update describes an active-not-recruiting clinical trial at the Abramson Cancer Center investigating polygenic risk scores and multi-cancer early detection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Ovarian Cancer, BRCA Mutation | Status: ACTIVE_NOT_RECRUITING